# Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome

> **NCT05444946** · NA · RECRUITING · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 104 (estimated)

## Conditions studied

- Chronic Pulmonary Aspergillosis
- Allergic Bronchopulmonary Aspergillosis

## Interventions

- **DRUG:** Prednisone tablet and Itraconazole
- **DRUG:** Oral itraconazole

## Key facts

- **NCT ID:** NCT05444946
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-15
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-02-01
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05444946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05444946, "Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05444946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*